FDA Defends Decision to Approve Digital Aripiprazole
Members of the US FDA go on the defensive over the agency’s decision to approve digital aripiprazole.
Stay updated with breaking news from Antipsychotics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Members of the US FDA go on the defensive over the agency’s decision to approve digital aripiprazole.
A new study finds that adding an antipsychotic to existing antidepressant treatment is associated with a 45% increased risk of early death.
Study finds that 74% of patients with a psychotic disorder off antipsychotics at end of 10 years are in remission.
A new analysis of antipsychotic treatment of schizophrenia has found that two-thirds of patients do not experience symptom remission.
A new study published this month in the journal Neuron identifies the mechanism by which antipsychotic drugs can induce parkinsonism.